Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ROIV | MRNA | ILMN | ||
| Company | Roivant Sciences Ltd | Moderna Inc | Illumina Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 28.34 | 51.27 | 127.96 | ||
| High | 28.97 | 53.62 | 134.76 | ||
| Low | 28.30 | 50.73 | 127.00 | ||
| Latest | 28.94 | 53.57 | 134.46 | ||
| Change | +0.45 | +1.86 | +7.06 | ||
| % Change | +1.58% | +3.60% | +5.54% | ||
| Volume | 4,313,500 | 9,069,700 | 4,008,700 | ||
| 20-Day Average Volume | 7,114,675 | 10,374,015 | 2,652,100 | ||
| Previous Close | 28.49 | 51.71 | 127.40 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 26.03 | 45.39 | 124.73 | ||
| 20-Day Raw Stochastic | 96.84% | 97.41% | 59.35% | ||
| 20-Day Relative Strength | 71.41 | 70.89 | 54.18 | ||
| Weighted Alpha | +201.88 | +111.75 | +51.24 | ||
| Today's Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 56% Buy | ||
| Last Month's Opinion | 80% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.59% since 02/20/26 | +7.42% since 02/20/26 | +14.27% since 02/20/26 | ||
| Low | 27.03 on 02/23/26 | 48.68 on 02/23/26 | 115.88 on 02/23/26 | ||
| High | 29.20 on 02/25/26 | 54.02 on 02/23/26 | 134.76 on 02/27/26 | ||
| 1-Month | |||||
| %Chg | +28.45% since 01/27/26 | +17.87% since 01/27/26 | -11.59% since 01/27/26 | ||
| Low | 20.98 on 02/02/26 | 36.65 on 02/11/26 | 112.65 on 02/12/26 | ||
| High | 29.20 on 02/25/26 | 54.02 on 02/23/26 | 152.78 on 01/28/26 | ||
| 3-Month | |||||
| %Chg | +38.67% since 11/26/25 | +114.19% since 11/26/25 | +3.58% since 11/26/25 | ||
| Low | 19.96 on 12/02/25 | 23.92 on 12/02/25 | 112.65 on 02/12/26 | ||
| High | 29.20 on 02/25/26 | 55.20 on 01/22/26 | 155.53 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +141.37% since 08/27/25 | +113.43% since 08/27/25 | +35.08% since 08/27/25 | ||
| Low | 11.85 on 08/29/25 | 22.28 on 11/21/25 | 88.00 on 10/14/25 | ||
| High | 29.20 on 02/25/26 | 55.20 on 01/22/26 | 155.53 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 20,712,388 | 21,156,882 | 20,558,934 | ||
| Shares Outstanding, K | 715,701 | 394,939 | 152,900 | ||
| Annual Sales | 29,050,000 | 1,944,000,000 | 4,343,000,000 | ||
| Annual Net Income | -171,980,000 | -2,822,000,000 | 850,000,000 | ||
| Last Quarter Sales | 2,000,000 | 678,000,000 | 1,159,000,000 | ||
| Last Quarter Net Income | -265,890,000 | -826,000,000 | 334,000,000 | ||
| 60-Month Beta | 1.22 | 1.32 | 1.45 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 02/06/26 | -2.11 on 02/13/26 | 1.35 on 02/05/26 | ||
| Latest Earnings Date | 06/04/26 | 05/07/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 26.27 | ||